| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |